Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

10.15 +0.04 (+0.45%)
Delayed Quote Updated: 1:22 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Dow Down 150 Points; US Durable Goods Orders Drop In February ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.50% to 31,944.01 while the NASDAQ fell 0.52%... 
Via Benzinga
News headline image
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday ↗
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher ↗
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported  
Via Benzinga
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Earnings Outlook For ADMA Biologics ↗
 
Via Benzinga
Looking Into ADMA Biologics's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 23, 2023 ↗
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
Conference Call Scheduled for March 23, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
7 A-Rated Penny Stocks Worth Betting On ↗
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
News headline image
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
News headline image
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
News headline image
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like... 
Via Benzinga
News headline image
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Proposed Public Offering of Common Stock
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's... 
Via Benzinga
News headline image
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million. 
Via Benzinga
News headline image
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
A Preview Of ADMA Biologics's Earnings ↗
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that ADMA... 
Via Benzinga
News headline image
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗
Upgrades 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.